Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paradigm Convergence Technologies Corp (PCT) is a holding company focused on sustainable cleaning and disinfection technologies, with applications in healthcare environmental surfaces. It operates through its subsidiary PCT Corp., producing solutions like Hydrolyte® via electro-chemical activation. The company is publicly traded on OTC with low market cap and 17 employees. No clinical pipeline, therapeutics, or pharma-related activities identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paradigm Convergence Technologies Corp.